Second, Third COVID-19 Vaccine May Up Relapse in Glomerular Disease
Absolute increase in 30-day relapse risk associated with the second or third vaccine dose is small
COVID-19 Tied to Higher Risk for New, Worsening Bladder Symptoms
Symptomatic infection tied to three times greater risk for developing new or worsening overactive bladder symptoms
COVID-19 mRNA Vaccines Tied to Higher Risk for Myocarditis, Pericarditis
Authors say benefits of vaccination still outweigh risks, but some individuals should be aware of their higher risk
Europe Approves Single-dose RSV Option for Infants
The European Commission became the first regulatory body to approve preventing respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants during their first RSV season with passive immunization.
AstraZeneca and Sanofi’s Beyfortus® (nirsevimab) approval in the European Union was announced on November 4, 2022.
However, the actual availability date in Europe was not disclosed today.
Pfizer Study Reveals Big Rise in Immunity From COVID-19 Booster
FDA says findings affirm its decision to approve the booster without human testing based on experience with a similarly tweaked vaccine
Age-Adjusted Rate of Alcohol-Induced Deaths Up From 2019 to 2020
Rates of alcohol-induced deaths in 2020 increased with age, peaking for those aged 55 to 64 years
mRNA-Based Influenza and COVID-19 Combo Vaccine Candidate Launches Study
Global leaders in vaccine innovation today announced the advancement of an mRNA-based vaccine candidate preventing both influenza and COVID-19 to a Phase 1 clinical trial.
The Pfizer Inc. and BioNTech SE vaccine candidate aims to address these severe respiratory diseases with one vaccine.
The vaccine candidate combines Pfizer's quadrivalent modRNA-based influenza vaccine candidate, qIRV (22/23), which is currently in Phase 3 clinical development, and Pfizer and BioNTech's authorized Omicron-adapted bivalent COVID-19 BNT162b2 (Original/Omicron BA.4/BA.5) vaccine.
Physicians Say Faulty Oxygen Devices Put Lives in Peril
Speaking to an expert panel during an FDA hearing, physicians cast doubt on the accuracy of pulse oximeters
AI Algorithm May ID Dysfunctional Immune Profiles in Acute Infection
Machine learning framework used to deploy quantitative sepsis response signature score, which was estimated using seven- or 12-gene signature